«People with hepatitis C are two to five times more likely to develop
certain head and neck cancers: first study to find association with new cancer types; findings have strong implications for screening and treatment.»
Long associated with liver cancer and non-Hodgkin's lymphoma, a study from The University of Texas MD Anderson Cancer Center reveals for the first time that the hepatitis C virus (HCV) is associated with
certain head and neck cancers.
Not exact matches
Although Merck's vaccine will be marketed only for cervical
cancer, preliminary evidence suggests it may also be effective against penile, anal,
and vulvar
cancers and even
certain cancers of the
head and neck.
Results of an initial study of tumors from patients with lung
cancer or
head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of
certain genetic mutations needed to enable the immune system to recognize
and attack malignant cells.
A class of therapeutic drugs known as protein kinase inhibitors has in the past decade become a powerful weapon in the fight against various life - threatening diseases, including
certain types of leukemia, lung
cancer, kidney
cancer and squamous cell
cancer of the
head and neck.
Amifostine protects good tissue during radiation in
certain cases such as
head and neck cancers.
Risk factors for
head and neck cancers include: tobacco use, heavy alcohol consumption, prolonged sun exposure,
and certain viruses, including human papillomavirus (HPV)
and Epstein - Barr virus (EBV).
Using data from national
cancer registries, CDC analysts looked for
certain cancer types — cervical,
head and neck,
and anal, among them — that have links to HPV.